Khi sức mạnh tính toán của AI cũng bắt đầu được "chia sẻ", ai sẽ trở thành người dẫn đầu trong cuộc cạnh tranh mới này?

EcoR1 Capital

company

About

EcoR1 Capital is a biotech-focused investment advisory firm.

  • 1 - 10

Details

Industries
Biotechnology,Financial Services
Founded date
Jan 1, 2012
Number Of Employee
1 - 10
Operating Status
Active
Investor Type
PE,Venture Capital

Investments

Number of Investments
Number of Lead Investments
13
3
EcoR1 Capital has made 13 investments. Their most recent investment was on Jan 6, 2022, when Eikon Therapeutics raised $518M.
Date Company Name
Round Money Raised Industry Lead Investor
Series B $518M Biotechnology
Series B $210M Biopharma Yes
Series B $162M Biotechnology Yes
Series A $110M Biotechnology Yes
Aug 26, 2020 Freenome
Series C $270M Biotechnology